The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase
Not applicable
Started
2024-09-30
Last updated
2024-10-01
Condition(s) studied
Knee Arthropathy
Investigational drug(s) / intervention(s)
CR prosthesisPS prosthesis
CR prosthesis: For patients undergoing simultaneous bilateral knee arthroplasty, different prostheses (CR vs. PS) were randomized to the left or right knee.
PS prosthesis: For patients undergoing simultaneous bilateral knee arthroplasty, different prostheses (CR vs. PS) were randomized to the left or right knee.
Study summary
Exploring differences in knee function after surgery with different types of prostheses(Cruciate ligament retaining(CR) VS. posterior stabilizing(PS))
Eligibility
Sex
ALL
Min age
45 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria:
1. Age 45-80 years, any gender, BMI \< 35 kg/m2
2. Initial diagnosis of bilateral knee OA (Kellgren-Lawrence classification grades 3 or 4). Patients who are to undergo simultaneous primary bilateral knee arthroplasty
3. Inversion deformity ≤ 15°
4. Posterior cruciate ligament integrity
Exclusion Criteria:
1. History of knee surgery (ligament, osteotomy, etc.)
2. knee flexion\<90°.
3. flexion contracture of one knee \> 10°
4. Comorbidity with other diseases, such as peripheral neuropathy, malignant tumors, rheumatism, etc.
5. Posterior cruciate ligament injury
6. Those assessed to be intolerant of surgery
Primary outcome measure(s)
Knee Society Score, KSS — 6 weeks, 3 months, 6 months, 12 months, 24 months after surgery Use of Knee Society Score scales for assessment. Including pain, mobility, stability, the patient\'s ability to walk, up and down the stairs, etc. on the assessment, 85-100 is excellent, 70-84 is good, 60-69 is pass, less than 60 is poor
Trial sites (1)
Facility
City
Region
Status
Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
Nanjing
Jiangsu
More The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.